APA (7th ed.) Citation

HK, S., K, B., DM, G., & OK, S. (2026). Stabilizers, Silencers, and Disease Stage: Lessons From Recent Trials of ATTR Cardiac Amyloidosis. Journal of the American College of Cardiology, 87(5), 502. https://doi.org/10.1016/j.jacc.2025.10.019

Chicago Style (17th ed.) Citation

HK, Siddiqi, Bhatt K, Gopal DM, and Siddiqi OK. "Stabilizers, Silencers, and Disease Stage: Lessons From Recent Trials of ATTR Cardiac Amyloidosis." Journal of the American College of Cardiology 87, no. 5 (2026): 502. https://doi.org/10.1016/j.jacc.2025.10.019.

MLA (9th ed.) Citation

HK, Siddiqi, et al. "Stabilizers, Silencers, and Disease Stage: Lessons From Recent Trials of ATTR Cardiac Amyloidosis." Journal of the American College of Cardiology, vol. 87, no. 5, 2026, p. 502, https://doi.org/10.1016/j.jacc.2025.10.019.